Arteriovenous Fistula Stenosis
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
AcotecChina - Beijing
2 programsdrug-coated balloon catheter （Orchid, Acotec）N/A1 trial
paclitaxel-coated balloon catheterN/A
Active Trials
Boston ScientificCA - Valencia
1 programRANGER™ Paclitaxel Coated Balloon CatheterN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Boston ScientificRANGER™ Paclitaxel Coated Balloon Catheter
Acotecdrug-coated balloon catheter （Orchid, Acotec）
MedtronicIN.PACT AV DCB
Clinical Trials (3)
Total enrollment: 760 patients across 3 trials
A Prospective, Multi-center Study to Evaluate Efficacy and Safety of BSJ020R in Treatment of AVF for Hemodialysis (RANGER AV Japan Study)
Start: Dec 2024Est. completion: Dec 2026186 patients
N/AActive Not Recruiting
AcoArt III / Arterio-venous Fistula in China
Start: May 2018Est. completion: Jul 2022244 patients
N/ACompleted
IN.PACT™ AV Access IDE Study
Start: Apr 2017Est. completion: May 2023330 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.